Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BMJ Open|March 21, 2013
Spectrum of novel mutations found in Waardenburg syndrome types 1 and 2: implications for molecular genetic diagnosticsGabriele Wildhardt, Birgit Zirn, Luitgard M Graul-Neumann, et al.
Clinical Pharmacology and Therapeutics|October 11, 2025
Clinical Implementation of Pharmacogenomics and Drug-Drug Interaction Screening in a German Academic Teaching Hospital and Outpatient Follow-UpRoman Tremmel, Filippa Schreeck, Simon Jaeger, et al.
Journal of the American Medical Informatics Association : JAMIA|February 15, 2018
Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) projectKathrin Blagec, Rudolf Koopmann, Mandy Crommentuijn-van Rhenen, et al.
Plos One|June 8, 2022
Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countriesKathrin Blagec, Jesse J Swen, Rudolf Koopmann, et al.
Breast (Edinburgh, Scotland)|January 24, 2025
Joint analysis of germline genetic data from over 29,000 cases with suspected hereditary breast and ovarian cancer (HBOC) as part of the NASGE initiativeJan Henkel, Andreas Laner, Melanie Locher, et al.
Human Mutation|January 6, 2017
EIF2S3 Mutations Associated with Severe X-Linked Intellectual Disability Syndrome MEHMOMartina Skopkova, Friederike Hennig, Byung-Sik Shin, et al.
Pharmacogenetics and Genomics|April 23, 2020
Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE studyCathelijne H van der Wouden, Stefan Böhringer, Erika Cecchin, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE StudyHenk-Jan Guchelaar, Cathelijne H van der Wouden, Lisanne E N Manson, et al.
Eclinicalmedicine|January 8, 2026
Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE studyVasileios Fragoulakis, Jesse J Swen, Margarita-Ioanna Koufaki, et al.
Lancet (London, England)|February 4, 2023
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J Swen, Cathelijne H van der Wouden, Lisanne En Manson, et al.
Pageof 2